European Archives - Page 1335 of 1449 - European Medical Journal

EMJ

Helsinn Presents Quality of Life, Its First Group Sustainability Report

Lugano, Switzerland, March 23, 2016: Helsinn Group is pleased to present its first group sustainability report, Quality of Life, demonstrating that…

EMJ

Baricitinib Fights the Biological Mechanism of Rheumatoid Arthritis

A CURE-LIKE state has been achieved in a new Phase III study exploring the effects of baricitinib in rheumatoid arthritis patients with poor responses to…

EMJ

Molecular Underpinning of Flexible Elastin Tissue Unveiled

MYSTERIOUS mechanisms of elastin tissue, a vital aspect of enabling our body to function, have finally been revealed through a novel combination of…

EMJ

Seaweed Spawns Solutions to Stem Cell Storage and Treatment

PARAMEDICS and physicians will soon see a cost-effective solution to stem cell use through the pragmatic use of seaweed to treat wounds, particularly in…

EMJ

STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy

STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy

EMJ

Sneaking through Barrier Gaps: Gut Microbiota Imbalance Harms the Liver

March 14, 2016: The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions only. Prominent among the other organs…

EMJ

New Human Papilloma Virus Vaccine Improves Cervical Cancer Protection

A VACCINE that protects against nine types of the human papilloma virus (HPV) has been developed by research scientists; this offers significantly…

EMJ

Gold is a Girl’s Best Friend: A New Treatment for Ovarian Cancer

GOLD could form part of the treatment for ovarian cancer, as according to new research a gold-containing drug could improve the prognosis of patients…

EMJ

Gut Profiling: New Biomarkers for Metabolic Diseases

March 11, 2016: For diagnosing or predicting metabolic diseases such as obesity, insulin resistance or type two diabetes (T2D), doctors commonly make use…

EMJ

Treatment Advances and New Centres of Excellence Offer Lifeline to Patients with Inoperable Neuroendocrine Cancers

1 March 2016: A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope…